EPIRUS Biopharmaceuticals, Inc. (EPRSQ) Stock Analysis
DELISTED
What happened to EPIRUS Biopharmaceuticals, Inc. (EPRSQ) stock?
EPIRUS Biopharmaceuticals, Inc. (EPRSQ) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
EPIRUS Biopharmaceuticals, Inc. (EPRSQ). EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing biosimilar therapeutics. The company filed for liquidation under Chapter 7 bankruptcy in 2016.
Last analyzed: Jun 1, 2026EPIRUS Biopharmaceuticals, Inc. (EPRSQ) Healthcare & Pipeline Overview
EPRSQ OTC Market Information
EPRSQ trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy EPRSQ shares?
No. EPRSQ stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for EPRSQ elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before EPRSQ stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to EPIRUS Biopharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.